Skip Navigation

European Heart Journal 1990 11(Supplement A):67-69; doi:10.1093/eurheartj/11.suppl_A.67
Copyright © 1990 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Mechelen, H.
Right arrow Articles by Rousseau, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Mechelen, H.
Right arrow Articles by Rousseau, M. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 The European Society of Cardiology

Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure

H. van Mechelen, A. Ries, H. Pouleur and M. F. Rousseau

Cardic Catheterisation and Intervention Cardiology Unit, Division of Cardiology and Department of Physiology, University of Louvain Brussels, Belgium

Detailed left ventricular haemodynamic investigations were perfonncd in eight patients with New York Heart Association (NYHA) Class II heart failure, eight with NYHA Class III heart failure with an ejection fraction < 35%, and six with severe heart failure. Xamoterol (200 mg b.d. for 3 months) caused a fall in left ventricular end-diastolic pressure, an increase in dP/dTmax and a shorter systole in all groups of patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HypertensionHome page
M. L. Muiesan, M. Salvetti, A. Paini, C. Agabiti-Rosei, C. Monteduro, G. Galbassini, E. Belotti, C. Aggiusti, D. Rizzoni, M. Castellano, et al.
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Hypertension, September 1, 2008; 52(3): 529 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. Camposilvan, O. Milanesi, G. Stellin, A. Pettenazzo, L. Zancan, and L. D'Antiga
Liver and Cardiac Function in the Long Term After Fontan Operation
Ann. Thorac. Surg., July 1, 2008; 86(1): 177 - 182.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. L. Muiesan, M. Salvetti, A. Paini, C. Monteduro, G. Galbassini, B. Bonzi, P. Poisa, E. Belotti, C. Agabiti Rosei, D. Rizzoni, et al.
Inappropriate Left Ventricular Mass Changes During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients
Hypertension, May 1, 2007; 49(5): 1077 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
E. Gerdts, K. Wachtell, P. Omvik, J. E. Otterstad, L. Oikarinen, K. Boman, B. Dahlof, and R. B. Devereux
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
Hypertension, February 1, 2007; 49(2): 311 - 316.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.